It helps to protect cells from free radicals and oxidative stress
The therapy may support various functions such as detoxification, promoting healthy skin, and assisting with cellular repair
The STEP clinical trial program enrolled over 10,000 participants and demonstrated: - **Average 1517% body weight loss** in clinical trials - **Preferential fat mass reduction** analysis published in *Diabetes, Obesity and Metabolism* showed the majority of weight lost was fat tissue - **Sustained results** STEP 5 trial showed maintained fat loss over 2 years - **Once-weekly injection** convenient dosing for bodybuilders and athletes For detailed dosing protocols, see our [semaglutide dosing schedule guide](/guides/semaglutide-dosing-schedule-week-by-week-guide)
Indeed, in the NAC arm in FAS population, two neonatal prematurity-related events were reported (with a diagnosis of sepsis and respiratory distress), whereas, in the placebo arm, fourteen events were diagnosed, due to seven diseases (4 cases of respiratory distress, 3 cases of BPD, 1 case of sepsis, 1 case of NEC, 2 cases of ROP, 3 cases of intraventricular hemorrhage) (Table 2A)